Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Merck & Company | Merck | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2004 | DOJ_CIVIL | $27,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
Pfizer Corporation | Pfizer | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Forest Laboratories and Forest Pharmaceuticals | AbbVie | False Claims Act and related | 2016 | DOJ_CIVIL | $38,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |
Sanofi-Pasteur | Sanofi | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
SmithKline Beecham | GlaxoSmithKline | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
Abbott Laboratories and CG Nutritionals | Abbott Laboratories | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | USAO | $3,500,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | USAO | $149,000,000 |
Depuy Orthopaedics Inc. | Johnson & Johnson | False Claims Act and related | 2007 | USAO | $84,700,000 |
Purdue Frederick Company Inc. | Purdue Pharma | False Claims Act and related | 2007 | USAO | $600,000,000 |
United Therapeutics Corporation | United Therapeutics | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
Abiomed, Inc. | Johnson & Johnson | False Claims Act and related | 2018 | USAO | $3,100,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
Allergan Inc. | AbbVie | False Claims Act and related | 2018 | USAO | $3,500,000 |
Pfizer, Inc. | Pfizer | False Claims Act and related | 2018 | DOJ_CIVIL | $23,850,000 |
Actelion Pharmaceuticals US, Inc. | Johnson & Johnson | False Claims Act and related | 2018 | DOJ_CIVIL | $360,000,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
Jazz Pharmaceuticals plc | Jazz Pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $57,000,000 |
Lundbeck LLC | Lundbeck | False Claims Act and related | 2019 | DOJ_CIVIL | $52,600,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2009 | IA-AG | $357,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
Actavis | AbbVie | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,860,779 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $600,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Amgen and Immunex | Amgen | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2004 | FL-AG | $807,826 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Daiichi Sankyo, Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | MULTI-AG | $39,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |